Citadel Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $315K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $196K | Sell |
|
|||||
|
2024
Q4 | $421K | Sell |
|
|||||
|
2024
Q3 | $513K | Buy |
|
|||||
|
2024
Q2 | $96.5K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $13.5K | Buy |
|
|||||
|
2023
Q3 | $267 | Buy |
|
|||||
|
2023
Q2 | – | Hold |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $863 | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $663K | Buy |
|
|||||
|
2021
Q4 | $165K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $78K | Sell |
|
|||||
|
2021
Q1 | $198K | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $42K | Sell |
|
|||||
|
2020
Q1 | $95K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $62K | Sell |
|
|||||
|
2018
Q3 | $182K | Buy |
|